Related references
Note: Only part of the references are listed.SPOP suppresses prostate cancer through regulation of CYCLIN E1 stability
Lin-Gao Ju et al.
CELL DEATH AND DIFFERENTIATION (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Cyclin D-CDK4 kinase destabilizes PD-L1 via cullin 3-SPOP to control cancer immune surveillance
Jinfang Zhang et al.
NATURE (2018)
Glioma epigenetics: From subclassification to novel treatment options
Olga Gusyatiner et al.
SEMINARS IN CANCER BIOLOGY (2018)
Speckle-type POZ protein suppresses hepatocellular carcinoma cell migration and invasion via ubiquitin-dependent proteolysis of SUMO1/sentrin specific peptidase 7
Piyou Ji et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Uterine function in the mouse requires speckle-type poz protein
Lan Hai et al.
BIOLOGY OF REPRODUCTION (2018)
The immunohistochemical expression and potential prognostic value of HDAC6 and AR in invasive breast cancer
Congying Li et al.
HUMAN PATHOLOGY (2018)
Speckle-type POZ protein as a diagnostic biomarker in renal cell carcinoma
Ashutosh Chauhan et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2018)
SPOP promotes ATF2 ubiquitination and degradation to suppress prostate cancer progression
Jian Ma et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
LINC01638 lncRNA activates MTDH-Twist1 signaling by preventing SPOP-mediated c-Myc degradation in triple-negative breast cancer
Liyun Luo et al.
ONCOGENE (2018)
Metastatic prostate cancer-associated P62 inhibits autophagy flux and promotes epithelial to mesenchymal transition by sustaining the level of HDAC6
Xianhan Jiang et al.
PROSTATE (2018)
Establishment and molecular characterization of a human ovarian clear cell carcinoma cell line (FDOV1)
Wei Jiang et al.
JOURNAL OF OVARIAN RESEARCH (2018)
SPOP promotes FADD degradation and inhibits NF-κB activity in non small cell lung cancer
Jie Luo et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Cancer Mutations of the Tumor Suppressor SPOP Disrupt the Formation of Active, Phase-Separated Compartments
Jill J. Bouchard et al.
MOLECULAR CELL (2018)
miR-372 and miR-373 enhance the stemness of colorectal cancer cells by repressing differentiation signaling pathways
Lu-Qin Wang et al.
MOLECULAR ONCOLOGY (2018)
SPOP promotes transcriptional expression of DNA repair and replication factors to prevent replication stress and genomic instability
Kim Hjorth-Jensen et al.
NUCLEIC ACIDS RESEARCH (2018)
miRNA-543 promotes cell migration and invasion by targeting SPOP in gastric cancer
Junfei Xu et al.
ONCOTARGETS AND THERAPY (2018)
Functional roles of Speckle-Type Poz (SPOP) Protein in Genomic stability
Xi Wei et al.
JOURNAL OF CANCER (2018)
Speckle-Type POZ Protein Down-Regulates Matrix Metalloproteinase 2 Expression via Sp1/PI3K/Akt Signaling Pathway in Colorectal Cancer
Shouhua Zhang et al.
DIGESTIVE DISEASES AND SCIENCES (2018)
The genetic landscape of endometrial clear cell carcinomas
Deborah F. DeLair et al.
JOURNAL OF PATHOLOGY (2017)
Prostate cancer-associated SPOP mutations confer resistance to BET inhibitors through stabilization of BRD4
Xiangpeng Dai et al.
NATURE MEDICINE (2017)
Intrinsic BET inhibitor resistance in SPOP-mutated prostate cancer is mediated by BET protein stabilization and AKT-mTORC1 activation
Pingzhao Zhang et al.
NATURE MEDICINE (2017)
Opposing effects of cancer-type-specific SPOP mutants on BET protein degradation and sensitivity to BET inhibitors
Hana Janouskova et al.
NATURE MEDICINE (2017)
SPOP regulates prostate epithelial cell proliferation and promotes ubiquitination and turnover of c-MYC oncoprotein
C. Geng et al.
ONCOGENE (2017)
Decreased expression of speckle-type POZ protein for the prediction of poor prognosis in patients with non-small cell lung cancer
Jing-Jing Li et al.
ONCOLOGY LETTERS (2017)
The genetic landscape of benign thyroid nodules revealed by whole exome and transcriptome sequencing
Lei Ye et al.
NATURE COMMUNICATIONS (2017)
Inherited determinants of early recurrent somatic mutations in prostate cancer
Alessandro Romanel et al.
NATURE COMMUNICATIONS (2017)
Cancer Statistics, 2017
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Somatic Mutation Profiles of Clear Cell Endometrial Tumors Revealed by Whole Exome and Targeted Gene Sequencing
Matthieu Le Gallo et al.
CANCER (2017)
Tumor suppressor SPOP ubiquitinates and degrades Eg1N2 to compromise growth of prostate cancer cells
Linli Zhang et al.
CANCER LETTERS (2017)
SPOP Mutation Drives Prostate Tumorigenesis In Vivo through Coordinate Regulation of PI3K/mTOR and AR Signaling
Mirjam Blattner et al.
CANCER CELL (2017)
SPOP promotes SIRT2 degradation and suppresses non-small cell lung cancer cell growth
Jie Luo et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Prostate cancer-associated mutation in SPOP impairs its ability to target Cdc20 for poly-ubiquitination and degradation
Fei Wu et al.
CANCER LETTERS (2017)
4-Hydroxybenzoic acid derivatives as HDAC6-specific inhibitors modulating microtubular structure and HSP90 alpha chaperone activity against prostate cancer
Carole Seidel et al.
BIOCHEMICAL PHARMACOLOGY (2016)
Targeting prostate cancer with compounds possessing dual activity as androgen receptor antagonists and HDAC6 inhibitors
Pradeep S. Jadhavar et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
TRIM24 Is an Oncogenic Transcriptional Activator in Prostate Cancer
Anna C. Groner et al.
CANCER CELL (2016)
Small-Molecule Targeting of E3 Ligase Adaptor SPOP in Kidney Cancer
Zhong-Qiang Guo et al.
CANCER CELL (2016)
Liquid-liquid phase separation in cellular signaling systems
P. Andrew Chong et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2016)
Higher-order oligomerization promotes localization of SPOP to liquid nuclear speckles
Melissa R. Marzahn et al.
EMBO JOURNAL (2016)
Genetic Progression of High Grade Prostatic Intraepithelial Neoplasia to Prostate Cancer
Seung-Hyun Jung et al.
EUROPEAN UROLOGY (2016)
SPOP promotes tumor progression via activation of -catenin/TCF4 complex in clear cell renal cell carcinoma
Wencai Zhao et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
Structural insights into the catalysis and regulation of E3 ubiquitin ligases
Lori Buetow et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2016)
SPOP Regulates Endometrial Stromal Cell Decidualization in Mice
Na Liu et al.
REPRODUCTIVE SCIENCES (2016)
Silencing speckle-type POZ protein by promoter hypermethylation decreases cell apoptosis through upregulating Hedgehog signaling pathway in colorectal cancer
Xiaofei Zhi et al.
CELL DEATH & DISEASE (2016)
Speckle-type POZ (pox virus and zinc finger protein) protein gene deletion in ovarian cancer: Fluorescence in situ hybridization analysis of a tissue microarray
Xiaoyu Hu et al.
ONCOLOGY LETTERS (2016)
Comprehensive Analysis of the Transcriptional and Mutational Landscape of Follicular and Papillary Thyroid Cancers
Seong-Keun Yoo et al.
PLOS GENETICS (2016)
Cullin 3 Ubiquitin Ligases in Cancer Biology: Functions and Therapeutic implications
Hsin-Yi Chen et al.
FRONTIERS IN ONCOLOGY (2016)
Cancer Statistics, 2015
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Characterisation of the Cullin-3 mutation that causes a severe form of familial hypertension and hyperkalaemia
Frances-Rose Schumacher et al.
EMBO MOLECULAR MEDICINE (2015)
Expression and significance of cortactin and HDAC6 in human prostatic foamy gland carcinoma
Huilian Hou et al.
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY (2015)
Properties and Clinical Relevance of Speckle-Type POZ Protein in Human Colorectal Cancer
Junfei Xu et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2015)
Progesterone action in breast, uterine, and ovarian cancers
Caroline H. Diep et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2015)
Truncated ERG Oncoproteins from TMPRSS2-ERG Fusions Are Resistant to SPOP-Mediated Proteasome Degradation
Jian An et al.
MOLECULAR CELL (2015)
SPOP Promotes Ubiquitination and Degradation of the ERG Oncoprotein to Suppress Prostate Cancer Progression
Wenjian Gan et al.
MOLECULAR CELL (2015)
Speckle-type POZ protein is negatively associated with malignancies and inhibits cell proliferation and migration in liver cancer
Yuping Huang et al.
TUMOR BIOLOGY (2015)
Endometrial cancer-associated mutants of SPOP are defective in regulating estrogen receptor-α protein turnover
P. Zhang et al.
CELL DEATH & DISEASE (2015)
Histone deacetylase 6 in health and disease
Carole Seidel et al.
EPIGENOMICS (2015)
SPOP E3 Ubiquitin Ligase Adaptor Promotes Cellular Senescence by Degrading the SENP7 deSUMOylase
Hengrui Zhu et al.
CELL REPORTS (2015)
SPOP mutation leads to genomic instability in prostate cancer
Gunther Boysen et al.
ELIFE (2015)
Expression of estrogen and progesterone receptors across human malignancies: new therapeutic opportunities
J. Munoz et al.
CANCER AND METASTASIS REVIEWS (2015)
Decreased expression of the SPOP gene is associated with poor prognosis in glioma
Dacheng Ding et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
Breast Cancer Statistics, 2013
Carol DeSantis et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2014)
Colorectal cancer statistics, 2014
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2014)
SPOP Promotes Tumorigenesis by Acting as a Key Regulatory Hub in Kidney Cancer
Guoqiang Li et al.
CANCER CELL (2014)
Androgen Receptor Is the Key Transcriptional Mediator of the Tumor Suppressor SPOP in Prostate Cancer
Chuandong Geng et al.
CANCER RESEARCH (2014)
The Emerging Genomic Landscape of Endometrial Cancer
Matthieu Le Gallo et al.
CLINICAL CHEMISTRY (2014)
Clinico-pathological significance of the molecular alterations of the SPOP gene in prostate cancer
Maria Garcia-Flores et al.
EUROPEAN JOURNAL OF CANCER (2014)
Exome Sequencing of Hepatoblastoma Reveals Novel Mutations and Cancer Genes in the Wnt Pathway and Ubiquitin Ligase Complex
Deshui Jia et al.
HEPATOLOGY (2014)
Differential expression of speckled POZ protein, SPOP: Putative regulation by miR-145
Chiu-Jung Huang et al.
JOURNAL OF BIOSCIENCES (2014)
SPOP suppresses tumorigenesis by regulating Hedgehog/Gli2 signaling pathway in gastric cancer
Chunyan Zeng et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2014)
SCF ubiquitin ligase-targeted therapies
Jeffrey R. Skaar et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Cleaning up in the endoplasmic reticulum: ubiquitin in charge
John C. Christianson et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2014)
Ubiquitylome analysis identifies dysregulation of effector substrates in SPOP-mutant prostate cancer
Jean-Philippe P. Theurillat et al.
SCIENCE (2014)
The Expression and Evaluation of Androgen Receptor in Human Renal Cell Carcinoma
Guodong Zhu et al.
UROLOGY (2014)
Structural basis of high-order oligomerization of the cullin-3 adaptor SPOP
Laura K. van Geersdaele et al.
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2013)
Intracellular protein degradation: From a vague idea through the lysosome and the ubiquitin-proteasome system and onto human diseases and drug targeting
Aaron Ciechanover
BIOORGANIC & MEDICINAL CHEMISTRY (2013)
The emerging family of CULLIN3-RING ubiquitin ligases (CRL3s): cellular functions and disease implications
Pascal Genschik et al.
EMBO JOURNAL (2013)
The mechanisms of Hedgehog signalling and its roles in development and disease
James Briscoe et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2013)
Prostate cancer-associated mutations in speckle-type POZ protein (SPOP) regulate steroid receptor coactivator 3 protein turnover
Chuandong Geng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Gastric cancer (GC) patients with hedgehog pathway activation: PTCH1 and GLI2 as independent prognostic factors
Su Jin Lee et al.
TARGETED ONCOLOGY (2013)
Molecular pathogenesis and mechanisms of thyroid cancer
Mingzhao Xing
NATURE REVIEWS CANCER (2013)
Regulatory networks defining EMT during cancer initiation and progression
Bram De Craene et al.
NATURE REVIEWS CANCER (2013)
Antiprogestins in breast cancer treatment: are we ready?
Claudia Lanari et al.
ENDOCRINE-RELATED CANCER (2012)
Insight in glioma susceptibility through an analysis of 6p22.3, 12p13.33-12.1, 17q22-23.2 and 18q23 SNP genotypes in familial and non-familial glioma
Yanhong Liu et al.
HUMAN GENETICS (2012)
Exome sequencing of serous endometrial tumors identifies recurrent somatic mutations in chromatin-remodeling and ubiquitin ligase complex genes
Matthieu Le Gallo et al.
NATURE GENETICS (2012)
Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer
Christopher E. Barbieri et al.
NATURE GENETICS (2012)
Common Musculoskeletal Tumors of Childhood and Adolescence
Carola A. S. Arndt et al.
MAYO CLINIC PROCEEDINGS (2012)
Adaptor Protein Self-Assembly Drives the Control of a Cullin-RING Ubiquitin Ligase
Wesley J. Errington et al.
STRUCTURE (2012)
Gli Proteins in Development and Disease
Chi-chung Hui et al.
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, VOL 27 (2011)
Breast cancer metastasis suppressor 1 (BRMS1) is destabilized by the Cul3-SPOP E3 ubiquitin ligase complex
Bogyou Kim et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Disruptive Events in the Life of Prostate Cancer
J. Chad Brenner et al.
CANCER CELL (2011)
The Role of HDAC6 in Cancer
Grace I. Aldana-Masangkay et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2011)
The genomic complexity of primary human prostate cancer
Michael F. Berger et al.
NATURE (2011)
Ubiquitin-like protein conjugation and the ubiquitin-proteasome system as drug targets
Lynn Bedford et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
The predator becomes the prey: regulating the ubiquitin system by ubiquitylation and degradation
Allan M. Weissman et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2011)
Tumor-suppressor role for the SPOP ubiquitin ligase in signal-dependent proteolysis of the oncogenic co-activator SRC-3/AIB1
C. Li et al.
ONCOGENE (2011)
Follicular Adenoma and Carcinoma of the Thyroid Gland
Christopher R. McHenry et al.
ONCOLOGIST (2011)
Mammalian Sirtuins: Biological Insights and Disease Relevance
Marcia C. Haigis et al.
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2010)
Pcif1 modulates Pdxl protein stability and pancreatic β cell function and survival in mice
Kathryn C. Claiborn et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Diverse somatic mutation patterns and pathway alterations in human cancers
Zhengyan Kan et al.
NATURE (2010)
Ten years of NAD-dependent SIR2 family deacetylases: implications for metabolic diseases
Shin-ichiro Imai et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2010)
RING Domain E3 Ubiquitin Ligases
Raymond J. Deshaies et al.
ANNUAL REVIEW OF BIOCHEMISTRY (2009)
Inhibition of HDAC6-dependent carcinogenesis: Emerging, new therapeutic options besides belinostat
Shailendra Kapoor
INTERNATIONAL JOURNAL OF CANCER (2009)
Structures of SPOP-Substrate Complexes: Insights into Molecular Architectures of BTB-Cul3 Ubiquitin Ligases
Min Zhuang et al.
MOLECULAR CELL (2009)
HDAC6 Regulates Androgen Receptor Hypersensitivity and Nuclear Localization via Modulating Hsp90 Acetylation in Castration-Resistant Prostate Cancer
Junkui Ai et al.
MOLECULAR ENDOCRINOLOGY (2009)
Sulforaphane destabilizes the androgen receptor in prostate cancer cells by inactivating histone deacetylase 6
Angela Gibbs et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Analysis of Drosophila Segmentation Network Identifies a JNK Pathway Factor Overexpressed in Kidney Cancer
Jiang Liu et al.
SCIENCE (2009)
BRMS1 suppresses breast cancer experimental metastasis to multiple organs by inhibiting several steps of the metastatic process
Pushkar A. Phadke et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Hedgehog Signaling in Development and Cancer
Jin Jiang et al.
DEVELOPMENTAL CELL (2008)
Diversity of degradation signals in the ubiquitin-proteasome system
Tommer Ravid et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
Genome-Wide and Functional Annotation of Human E3 Ubiquitin Ligases Identifies MULAN, a Mitochondrial E3 that Regulates the Organelle's Dynamics and Signaling
Wei Li et al.
PLOS ONE (2008)
Amplicon mapping and expression profiling identify the fas-associated death domain gene as a new driver in the 11q13.3 amplicon in Laryngeal/Pharyngeal cancer
Johan H. Gibcus et al.
CLINICAL CANCER RESEARCH (2007)
BTB/POZ domain of speckle-type POZ protein (SPOP) confers proapoptotic function in HeLa cells
Boohyeong Byun et al.
BIOFACTORS (2007)
Opinion - Inherited epigenetic variation - revisiting soft inheritance
EJ Richards
NATURE REVIEWS GENETICS (2006)
Pathogenetic mechanisms in thyroid follicular-cell neoplasia
T Kondo et al.
NATURE REVIEWS CANCER (2006)
Phosphorylated FADD induces NF-κB, perturbs cell cycle, and is associated with poor outcome in lung adenocarcinomas
GA Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor
JJ Kovacs et al.
MOLECULAR CELL (2005)
Sustained Hedgehog signaling is required for basal cell carcinoma proliferation and survival: conditional skin tumorigenesis recapitulates the hair growth cycle
ME Hutchin et al.
GENES & DEVELOPMENT (2005)
Function and regulation of Cullin-RING ubiquitin ligases
MD Petroski et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2005)
The BTB protein MEL-26 is a substrate-specific adaptor of the CUL-3 ubiquitin-ligase
L Pintard et al.
NATURE (2003)
BTB proteins are substrate-specific adaptors in an SCF-like modular ubiquitin ligase containing CUL-3
L Xu et al.
NATURE (2003)
Sonic hedgehog-dependent activation of Gli2 is essential for embryonic hair follicle development
P Mill et al.
GENES & DEVELOPMENT (2003)
Targeting of protein ubiquitination by BTB-Cullin 3-Roc1 ubiquitin ligases
M Furukawa et al.
NATURE CELL BIOLOGY (2003)
Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase
S Imai et al.
NATURE (2000)
Basal cell carcinomas in mice overexpressing Gli2 in skin
M Grachtchouk et al.
NATURE GENETICS (2000)
Frequency of oestrogen and progesterone receptor positivity by immunohistochemical analysis in 7016 breast carcinomas: correlation with patient age, assay sensitivity, threshold value, and mammographic screening
A Rhodes et al.
JOURNAL OF CLINICAL PATHOLOGY (2000)
Share Paper
